Related Experiment Video
Updated: Apr 15, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Simultaneous inference of a misclassified outcome and competing risks failure time data
1Division of Biostatistics, The University of Texas Health Science Center at Houston, 1200 Pressler St, Houston, TX 77030, USA ( sheng.t.luo@uth.tmc.edu ;
Abstract:
Ipsilateral breast tumor relapse (IBTR) often occurs in breast cancer patients after their breast conservation therapy. The IBTR status' classification (true local recurrence versus new ipsilateral primary tumor) is subject to error and there is no widely-accepted gold standard. Time to IBTR is likely informative for IBTR classification because new primary tumor tends to have a longer mean time to IBTR and is associated with improved survival as compared with the true local recurrence tumor. Moreover, some patients may die from breast cancer or other causes in a competing risk scenario during the follow-up period. Because the time to death can be correlated to the unobserved true IBTR status and time to IBTR (if relapse occurs), this terminal mechanism is non-ignorable. In this article, we propose a unified framework that addresses these issues simultaneously by modeling the misclassified binary outcome without a gold standard and the correlated time to IBTR, subject to dependent competing terminal events. We evaluate the proposed framework by a simulation study and apply it to a real dataset consisting of 4, 477 breast cancer patients. The adaptive Gaussian quadrature tools in SAS procedure NLMIXED can be conveniently used to fit the proposed model. We expect to see broad applications of our model in other studies with a similar data structure.
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
Assumptions of Survival Analysis
Kaplan-Meier Approach
Censoring Survival Data
Hazard Rate
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...

